Clinical Trial Update: Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the safety of fenfluramine in children with Dravet syndrome under 24 months; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome

Drugs mentioned

• Fenfluramine (fenfluramine)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Dravet Syndrome (DS), Children Under 2 Years | Phase 4 | Status: RECRUITING